The NFκB as well as other signaling pathways, including the mitogen-activated protein kinases (MAPKs) and the mammalian target of rapamycin (mTOR) signaling pathway, play important roles in HCC development and progression3–5. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.